Clinical Trial Results

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PHASE4INTERVENTIONAL Huntsville, Alabama +4 more

RECRUITING

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

PHASE3INTERVENTIONAL Fairhope, Alabama +4 more

RECRUITING

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

PHASE2, PHASE3INTERVENTIONAL Decatur, Alabama +4 more

RECRUITING

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

PHASE3INTERVENTIONAL Huntsville, Alabama +4 more

RECRUITING

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

PHASE3INTERVENTIONAL Huntsville, Alabama +4 more

RECRUITING

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

PHASE3INTERVENTIONAL Sun City, Arizona +4 more

RECRUITING

A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

NAINTERVENTIONAL Washington D.C., District of Columbia +2 more

RECRUITING

ARPKD Database Study

N/AOBSERVATIONAL Washington D.C., District of Columbia +4 more

RECRUITING

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease

PHASE2, PHASE3INTERVENTIONAL Alabaster, Alabama +4 more

RECRUITING

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

PHASE3INTERVENTIONAL Washington D.C., District of Columbia +4 more

RECRUITING

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease

NAINTERVENTIONAL Washington D.C., District of Columbia

RECRUITING

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

NAINTERVENTIONAL Washington D.C., District of Columbia +1 more

RECRUITING

Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

PHASE4INTERVENTIONAL Washington D.C., District of Columbia

RECRUITING

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

N/AOBSERVATIONAL Washington D.C., District of Columbia +3 more

RECRUITING

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

PHASE2INTERVENTIONAL Decatur, Alabama +4 more

RECRUITING

A Natural History Study of Metabolic Sizing in Health and Disease

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

Immune System Related Kidney Disease

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease

PHASE2INTERVENTIONAL Los Angeles, California +4 more

RECRUITING